
Prevention & Lipids
Blood pressure targets and treatment strategies
Synthesized from 134 evidence-backed clinical questions linked to this topic — 36 supporting the intervention, 42 against the intervention, 10 still contested.
No clear lean — the placed evidence is contested
36
Favor benefit
27% of all
42
Favor harm
31% of all
46 more (34%) still untested — not placed on the axis.
Low certainty on 58% of questions
Does antihypertensive drugs vs placebo improve outcomes in Frailty?
Low Certainty+ Favors benefitantihypertensive drugs vs placebo
7 studies (8,985,214 patients) provide low-certainty evidence for benefit of antihypertensive drugs for the outcome in Frailty.
Does antihypertensive vs placebo improve outcomes in Stroke?
Low Certainty− Favors harmantihypertensive vs placebo
8 studies (5,289,215 patients) provide low-certainty evidence against benefit of antihypertensive for the outcome in Stroke.
Does angiotensin receptor blockers vs placebo improve outcomes in Hypertensive disease?
Low Certainty− Favors harmangiotensin receptor blockers vs placebo
26 studies (3,889,575 patients) provide low-certainty evidence against benefit of angiotensin receptor blockers for the outcome in Hypertensive disease.
Does statin vs placebo improve outcomes in Hypertensive disease?
Low Certainty− Favors harmstatin vs placebo
13 studies (1,558,581 patients) provide low-certainty evidence against benefit of statin for the outcome in Hypertensive disease.
Does metoprolol vs propranolol improve outcomes in Hypertensive disease?
Low Certainty− Favors harmmetoprolol vs propranolol
6 studies (1,051,130 patients) provide low-certainty evidence against benefit of metoprolol for the outcome in Hypertensive disease.
Does diuretics vs placebo improve outcomes in Hypertensive disease?
Low Certainty− Favors harmdiuretics vs placebo
26 studies (903,774 patients) provide low-certainty evidence against benefit of diuretics for the outcome in Hypertensive disease.
Does antihypertensives vs placebo improve outcomes in Hypertensive disease?
Insufficient~ Mixed resultsantihypertensives vs placebo · Cardiac Output
452 studies (266,807,266 patients) provide insufficient evidence with mixed findings regarding antihypertensives for Cardiac Output in Hypertensive disease.
Does angiotensin converting enzyme inhibitor vs angiotensin receptor blocker improve outcomes in Hypertensive disease?
Insufficient~ Mixed resultsangiotensin converting enzyme inhibitor vs angiotensin receptor blocker
10 studies (7,152,153 patients) provide insufficient evidence with mixed findings regarding angiotensin converting enzyme inhibitor for the outcome in Hypertensive disease.
Does amlodipine vs chlorthalidone improve outcomes in Hypertensive disease?
Insufficient~ Mixed resultsamlodipine vs chlorthalidone
8 studies (136,774 patients) provide insufficient evidence with mixed findings regarding amlodipine for the outcome in Hypertensive disease.
Does antihypertensive drugs vs diuretic improve outcomes in Hypertensive disease?
Insufficient~ Mixed resultsantihypertensive drugs vs diuretic
6 studies (7,903,740 patients) provide insufficient evidence with mixed findings regarding antihypertensive drugs for the outcome in Hypertensive disease.
Emerging evidence with 100 primary claims
Angiotensin-Converting Enzyme Inhibitors in Essential Hypertension
Journal of Cardiovascular Pharmacology — Zanchetti A — Jan 1987
Calcium Antagonists in Antihypertensive Combination Therapy
Journal of Cardiovascular Pharmacology — Hansson L — Jan 1991
Antihypertensive treatment with diuretics: antediluvian or up to date?
Nephrology Dialysis Transplantation — Mees E — Apr 1996
Alpha1-blocker combination therapy for hypertension
Postgraduate Medicine — Houston M — Sep 1998
Visfatin Level and The Risk of Hypertension and Cerebrovascular Accident: A Systematic Review and Meta-Analysis
Hormone and Metabolic Research — Yu P — Apr 2019
A MAP toward increased rates of blood pressure control?
Journal of Clinical Hypertension — Peck R — Jan 2018
Matchmaking and the Future of Hypertension Management
Circulation Cardiovascular Quality and Outcomes — Murphy A — Dec 2020
Reservoir Pressure Integral Is Independently Associated With the Reduction in Renal Function in Older Adults
Hypertension — Aizawa K — Sep 2022
The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents
International Journal of Clinical Practice — MacDonald T — Apr 2010
Autonomic control of blood pressure and heart rate in obese hypertensive dogs
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology — Truett A — Mar 1996
INFLUENCE OF CIRCADIAN TIME AND AGE ON GLOMERULAR ANGIOTENSIN II RECEPTORS IN NORMOTENSIVE SPRAGUE-DAWLEY AND TRANSGENIC HYPERTENSIVE TGR(mREN2)27 RATS
Chronobiology International — Lemmer B — Jan 2001
Tempol in the Dorsomedial Hypothalamus Attenuates the Hypertensive Response to Stress in Rabbits
American Journal of Hypertension — DEMATTEO R — Mar 2006
The evidence sections above show what the literature supports; this is what the field is still arguing about. Open a debate for the camps, the named voices, and the vote.
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Hypertension management (also known as HTN, high blood pressure, BP management). Blood pressure targets and treatment strategies
As of 2026-09-01, the scientific consensus on Hypertension management is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/hypertension-management.
Deterministic synthesis from Synapse's enriched corpus — 57 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Hypertension management paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Hypertension management papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers
Sinopec (China)
h-index 210 · 260k citations
Most-cited researchers publishing on Hypertension management.